• About
  • Advertise
  • Contact
Thursday, August 18, 2022
  • Login
WRITE FOR US
Economy.pk
  • Economy
  • Politics
  • Technology
  • Education
  • Life & Style
  • Health
  • World
No Result
View All Result
Economy.pk
  • Economy
  • Politics
  • Technology
  • Education
  • Life & Style
  • Health
  • World
Economy.pk
Home Business

Searle strikes a deal to make Covid vaccines in Pakistan

bySidra Butt
April 2, 2021
in Business, Health, Main, New
Reading Time: 2 mins read
0
Searle Chinese firm strikes a deal
52
SHARES
800
VIEWS
Share on FacebookShare on Twitter

On Thursday, A local pharmaceutical company has signed a deal with a Chinese giant that allowed it to supply and produce an upcoming Covid-19 vaccine in Pakistan.

This has emerged in a letter written by M/s Searle Company Limited to the Pakistan Stock Exchange, saying it had concluded an agreement with China’s Livzon Mapharm Inc. for manufacturing a novel coronavirus vaccine (V-01) in Pakistan.

RelatedPosts

Govt to borrow Rs6.8tr from banks

5% tax on manufacturers to be expected

Honda Atlas also reduces car prices after rupee’s recovery

“Searle Company has concluded an exclusive licensing and supply agreement with Livzon Mapharm Inc. for the Recombinant Novel Coronavirus Vaccine (V-01). The licensing agreement also covers the manufacturing transition of (V-01) in Pakistan,” the company said.

The communique suggested that the vaccine was in the final phases of its trial which suggested promising results. The company expressed the hope that it would add value to the overall exercise against the pandemic.

“The Recombinant Novel Covid-19 Vaccine (V-01) developed by Livzon has shown promising results in phase 1 & Il clinical trial,” the letter said. “The phase Ill clinical study will include multiple countries and enroll more than 20,000 subjects, with the aim to evaluate the efficacy, safety, and immunogenicity of the V-01 program.”

The company said that among the many new Covid-19 vaccine projects being developed around the world, V-01 had many potential advantages such as a strong safety profile, high neutralizing antibody titer in vivo, long durability, and easy to scale up for manufacturing. “Searle is confident that in the existing pandemic, the relevant authorities will take up the matter on [an] urgent basis & support for fast-track approval to carry out phase III clinical trials in Pakistan,” it added.

Tags: Chinacovid 19Livzon MapharmPakistan Stock ExchangeV-01
Sidra Butt

Sidra Butt

Related Posts

Govt to borrow Rs6.8tr from banks

Govt to borrow Rs6.8tr from banks

The government has planned to borrow Rs6.78 trillion from commercial banks over a period of two months "August and September...

5% tax on manufacturers to be expected

5% tax on manufacturers to be expected

The government may impose a 5% special income tax on manufacturers to create fiscal space for giving a relief of...

Next Post
deficit

Pakistan’s Trade deficit blows up to $2.968 billion in March

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

Homeless man, Daughter sell balloons to Pay for Education

Homeless man, daughter sell balloons to Pay for Education

FIFA’s Official Website Removes Israel to Add Palestine in Its List of Countries

FIFA’s Official Website Removes Israel to Add Palestine in Its List of Countries

Govt to borrow Rs6.8tr from banks

Govt to borrow Rs6.8tr from banks

5% tax on manufacturers to be expected

5% tax on manufacturers to be expected

Honda Atlas also reduces car prices after rupee’s recovery

Honda Atlas also reduces car prices after rupee’s recovery

Stocks gain 240 points on strong corporate results

Stocks gain 240 points on strong corporate results

Connect with us

Twitter

Economy.pk

Economy.pk touches diverse topics with a lighter note and is geared toward audiences with various interests and all ages. Come and explore Economy.pk. Ample details and analysis are provided in extraordinarily readable manner making them compelling and interesting at the same time.

Category

  • World
  • Politics
  • Business
  • Technology
  • Education
  • Health
  • Life & Style
  • Opinions

Social Media

  • Facebook
  • Instagram
  • Twitter
  • Linkedin

Sitelinks

  • Sitemap

Download our APP

download on android app download on apple app
  • About
  • Advertise
  • Contact

© 2022 All Rights Reserved Economy.pk | Designed & Developed by Digital Otters

  • LATEST
  • World
    • Europe
    • Americas
    • Asia
    • Oceania
    • Africa
    • Canada
    • Middle East
  • Finance
  • Politics
  • Business
    • Economy
    • Finance
    • Entrepreneurship
    • Real Estate
  • Technology
    • Cyber Security
    • Mobiles
    • Social Media
  • Education
  • Sports
  • Life & Style
    • Personalities
    • Art
    • Culture
    • History
    • Entertainment
    • Fashion
    • Food
    • Health
      • Environment
      • Fitness
  • Sponsored

© 2022 All Rights Reserved Economy.pk | Designed & Developed by Digital Otters

No Result
View All Result

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In